Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing

Simple item page
dc.contributor.authorCavallari, Larisa H.
dc.contributor.authorPratt, Victoria M.
dc.contributor.departmentMedical and Molecular Genetics, School of Medicine
dc.date.accessioned2024-05-14T10:22:24Z
dc.date.available2024-05-14T10:22:24Z
dc.date.issued2022
dc.eprint.versionAuthor's manuscript
dc.identifier.citationCavallari LH, Pratt VM. Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing. Clin Lab Med. 2022;42(4):533-546. doi:10.1016/j.cll.2022.09.009
dc.identifier.urihttps://hdl.handle.net/1805/40706
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/j.cll.2022.09.009
dc.relation.journalClinics in Laboratory Medicine
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectEvidence
dc.subjectGenotype
dc.subjectOutcomes
dc.subjectPharmacogenomics
dc.subjectReimbursement
dc.titleBuilding Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Cavallari2022Building-AAM.pdf
Size:
314.6 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles